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Abstract
Background: Venoms comprise mixtures of numerous bioactive compounds that have a wide range of
pharmacologic actions. Toxins from venomous animals have attracted the attention of researchers because of their
affinity for primary sites responsible for lethality and their efficacy at extremely low concentrations. The venoms of
marine stingrays have not been extensively studied and limited data is available on them. The present study aims
to evaluate the antiproliferative and biochemical properties of the venom obtained from a species of marine
stingray (Dasyatis sephen) on human cervical cancer cell line HeLa.
Methods: The antiproliferative effect of D. sephen venom was determined by MTT assay, and the oxidative stress
was determined by lipid peroxidation method along with assessment of changes in the enzymatic and non-
enzymatic antioxidant status. We observed intracellular reactive oxygen species (ROS) levels by DCFH-DA method,
mitochondrial membrane potential alterations by rhodamine 123 staining and apoptotic morphological changes by
acridine orange/ethidium bromide dual staining method.
Results: D. sephen venom enhances lipid peroxidative markers such as thiobarbituric acid reactive substance,
conjugated diene, and lipid hydroperoxide in HeLa cell lines. Stingray venom enhances the ROS levels, which is
evidenced by the increased 2–7-diacetyl dichlorofluorescein fluorescence. Further, D. sephen venom treatment
altered the mitochondrial membrane potential in HeLa cells. Additionally, we observed increased apoptotic
morphological changes in D. sephen venom-treated groups.
Conclusions: Dasyatis sephen venom exhibits potent antiproliferative effect on HeLa cell line and upon further
purification it could be a promising antiproliferative agent.
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Background
Marine organisms comprise approximately one-half of
the total global biodiversity; therefore, they offer an
important source for novel compounds that has been
classified as the largest reservoir of natural molecules to
be evaluated for drug activity [1]. A different type of
environment exists in the ocean, where organisms live in
competitive and aggressive surroundings that differ in
many aspects from the terrestrial environment. This
competitive environment demands the production of
quite specific and potent active molecules by marine
organisms [2]. These organisms have been continuously
screened for pharmacologically active substances and till
date over 6500 marine natural products have been
isolated [3].
Cancer is characterized by the uncontrolled growth and
spreading of abnormal cells. In normal cell function and
tissue homeostasis, proliferation and apoptosis are bal-
anced. Cancer cells display abnormal in vivo proliferation
that is not balanced by compensatory apoptosis [4]. Apop-
tosis, defined as a controlled form of cell death, might
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represent a pivotal point in cancer treatment development
[5]. For the past few decades, venom components have be-
come the focus of researchers and have been extensively
studied for their various anticancer properties with effect-
ive inhibition of proliferation. The anticancer potential of
venom on adenocarcinoma cells was first reported for
Naja snake venoms by Calmette et al. [6]. In addition, bee
venom has also proven to have antiproliferative activity in
vitro and ability to reduce tumor growth in vivo [7].
Scorpion venom toxins demonstrate antiproliferative
activity against human glioma and leukemic cells as
well [8, 9]. Marine environment is highly diverse and
several compounds from marine origin have been ap-
proved for clinical use, including vidarabine (recurrent
epithelial keratitis and superficial keratitis), cytarabine
(cancer), ziconotide (chronic pain in cancer or AIDS),
trabectedin (soft tissue sarcoma) and halaven (meta-
static breast cancer) [10, 11]. But, concerning fish
venoms, limited data are available about their bio-
active potential.
Marine stingrays are venomous fish of the Elasmo-
branch family and are mainly found in temperate and
tropical areas of the world. Stingrays are considered to
be one of the most significant venomous fish in the
world [12]. They have serrated spines at the base of the
tail that penetrate the body of the victim. The epidermal
covering of the spine releases venom into the sting site
causing severe pain and tissue necrosis [13]. Stingray
venom exhibits neurotoxic, cardiotoxic, fibrinogenolytic
and anticoagulant activities and are composed of pro-
teins, serotoxin, vasoconstrictor peptides and several
other unidentified components [14–18]. In this study,
the mechanism by which the venom of the marine sting-
ray D. sephen inhibits cell proliferation and the associ-




Bovine serum albumin, thiobarbituric acid (TBA),
phenazine methosulphate (PMS), nitroblue tetrazolium
(NBT), 5,5-dithiobis(2-nitrobenzoic acid) (DTNB), 3-
(4,5-dimethyl-2-thiaozolyl)-2,5-diphenyl-2H-tetrazo-
lium bromide (MTT), 2–7-diacetyl dichlorofluorescein
(DCFH-DH), rhodamine 123 (Rh-123), acridine or-
ange, ethidium bromide, heat inactivated fetal calf
serum (FCS), minimum essential medium (MEM),
McCoy’s modified medium, glutamine, penicillin-
streptomycin, EDTA and trypsin were purchased from
Sigma Chemicals Co. (USA).
Venom extraction
Stingray specimens were collected from Parangipettai
coast (11°30’1.19“N 79°46’20.50”E, Tamil Nadu, India) by
local fishermen. The spines that are usually discarded by
fishermen due to the lack of commercial value were re-
moved from the base of the tail and transported to the
laboratory in an icebox. The tissue covering the stingers
was scratched and homogenized in PBS buffer, pH 7.4
and centrifuged at 5000 × g for 10 min. The supernatant
(venom) was stored at − 20 °C until use [19]. Protein
concentration of the supernatant was estimated by
standard method using BSA as protein standard. Details
about the D. sephen and stinger images are provided in
Additional file 1.
Cell lines and culture conditions
The present work was carried out on human cervical
cancer cell line (HeLa). The cell line was obtained from
the National Centre for Cell Science (NCCS), Pune,
India. HeLa cells were grown as monolayer in MEM
medium supplemented with 10 % FCS, 2mM glutamine,
and 100 U/mL penicillin-streptomycin at 37 °C in 5 %
CO2 atmosphere. Stocks were maintained in 25 cm
2 tis-
sue culture flasks.
Study group and dose fixation study
Cells were treated with different concentrations of sting-
ray venom (2, 4, 8, 12, 16, 20 or 24 μg/mL) and the cyto-
toxicity was observed by MTT assay. PBS used as
a sham control. The results assessed by MTT assay were
employed in further experiments in which five groups
were defined based on the venom administration doses:
 Group I: untreated HeLa cells (control)
 Group II: HeLa cells +D. sephen venom (4 μg/mL)
 Group III: HeLa cells +D. sephen venom (8 μg/mL)
 Group IV: HeLa cells +D. sephen venom (12 μg/mL)
 Group V: HeLa cells +D. sephen venom (16 μg/mL)
Drug sensitivity assay
The growth inhibitory activity of cells was determined
by the MTT assay based on the detection of mitochon-
drial dehydrogenase activity in living cells [20]. Each cul-
ture well was incubated for 24 h with different doses of
D. sephen venom. Ten microliters of MTT solution
(5 mg/mL in PBS) was added and incubated for 4 h to
allow color development. An equal volume of DMSO
was then added to stop the reaction and to solubilize the
blue crystals formed. The absorbance was taken at the
wavelength of 570 nm.
Measurement of intracellular ROS in cells by
spectrofluorimetric and fluorescence microscopic
methods
Intracellular ROS was measured by using a nonfluorescent
probe, DCFH-DA, which penetrates into the intracellular
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matrix of cells to be oxidized by ROS to fluorescent
dichlorofluorescein (DCF) [21]. Cells were incubated for
24 h with different concentrations of D. sephen venom.
Fluorescent dye DCFH-DA was then added to the cells
and incubated for 30 min. The cells were washed with
PBS to remove the excess dye before fluorescent measure-
ments that were carried out with excitation and emission
filters set at 485 ± 10 and 530 ± 12.5 nm, respectively
(Shimadzu RF-5301 PC Spectrofluorometer, Japan). Fluor-
escence microscopic images were taken using blue filter
(450–490 nm) (Nikon, Eclipse TS100, Japan).
Alterations in mitochondrial membrane potential
After cell incubation with D. sephen venom for 24 h,
fluorescent dye Rh-123 (10 μg/mL) was added to the
cells. The cells were then incubated for 30 min, washed
with PBS and analyzed in fluorescence microscope using
blue filter [21]. Polarized mitochondria were marked by
orange-red fluorescence, and depolarized mitochondria
were marked by green fluorescence.
Apoptotic morphological changes by acridine orange-
ethidium bromide dual staining method
Staining of DNA with acridine orange (AO) and ethidium
bromide (EBr) allowed visualization of the condensed
chromatin of dead apoptotic cells [21]. Stained cells were
viewed under a fluorescence microscope. The number of
cells showing features of apoptosis was counted as a func-
tion of the total number of cells present in the field.
Estimation of lipid peroxidation markers
The cells were harvested by trypsinization. The pellet
obtained was suspended in PBS and taken for the meas-
urement of lipid peroxidative markers such as thiobarbi-
turic acid reactive substances (TBARS), conjugated dines
(CD), and lipid hydro peroxide (LHP), according to the
procedures described elsewhere [22–24].
Estimation of antioxidant enzyme activity
The supernatant obtained after centrifuging the trypsi-
nized cells was used for the measurement of activities of
antioxidant enzymes, superoxide dismutase (SOD), cata-
lase (CAT), and glutathione peroxidase (GPx), according
to the procedures described elsewhere [25–27]
Estimation of reduced glutathione levels
The levels of reduced glutathione (GSH) were deter-
mined in the supernatant obtained after centrifuging the
trypsinized cells according to the procedures described
elsewhere [28].
Statistical analysis
Statistical analysis was performed using one way analysis
of variance (ANOVA) followed by Duncan’s multiple
range test (DMRT) by using Statistical Package of Social
Science (SPSS) version 12.0 for Windows. The values
were expressed as mean ± SD for six samples in each
group. In addition, p value of < 0.05 was considered as
statistically significant.
Results
Effect of D. sephen venom on cell proliferation
Effect of D. sephen venom on cell proliferation was de-
termined by MTT assay. The proliferation of HeLa cells
was significantly inhibited by D. sephenvenom. Figure 1
shows the changes in the percentage of cell death in con-
trol and venom-treated cells. The treatment with 2 μg/mL
of D. sephen venom did not show significant (p < 0.05)
proliferation inhibition. The treatment with 4, 8, 12 and
16 μg/mL of D. sephen venom significantly inhibited in
HeLa cells. Concentrations of 16 and 20 μg/mL displayed
almost the same inhibitory effect (80 and 81 % inhibition)
on HeLa cells. Hence, for further tests D. sephen venom
concentrations of 4, 8, 12 and 16 μg/mL were used on
HeLa cells.
D. sephen venom generates intracellular ROS
Levels of ROS in control and D. sephen venom-treated
cells are depicted in Fig. 2 – A (i) and B (i). Venom
treatment significantly increased ROS level in HeLa
cells. Venom concentrations of 4, 8, 12, and 16 μg/mL
increased ROS levels to 12, 30, 63 and 75 %, respectively,
when compared to control group. Among all tested
doses, 16 μg/mL showed maximum generation of ROS
in HeLa cells.
D. sephen venom modulates mitochondrial membrane
potential
Changes in mitochondrial membrane potential in con-
trol and D. sephen venom-treated cells are depicted in
Fig. 2 – A (ii) and B (ii). D. sephen venom treatment
significantly increased mitochondrial depolarization in
HeLa cells. After 24-hour incubation, venom treated
cells showed significantly decreased mitochondrial mem-
brane potential to 57, 35, 18, and 10 % at 4, 8, 12, and
16 μg/mL concentrations of D. sephen venom in HeLa
cells, respectively, when compared to control group.
Among all the doses tested, 16 μg/mL of D. sephen venom
showed the highest level of mitochondrial depolarization
in HeLa cells. Polarized mitochondria were marked by
orange-red fluorescence and depolarized mitochondria
were marked by green fluorescence.
Effect of D. sephen venom on apoptotic morphological
changes
Figure 2 – A (iii) and B (iii) show the effect of D. sephen
venom on apoptotic morphological changes. Figure 2 –
A (iii) shows the fluorescence microscopic observation
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of the untreated and treated cancer cells. Untreated can-
cer cells appeared in green (AO stained) whereas venom
treated cells appeared in red/orange (EtBr stained) that
revealed the presence of apoptotic cells. Figure 2 – B
(iii) shows the percentage of apoptosis. Venom concen-
trations of 4, 8, 12, and 16 μg/mL increased apoptotic
cells levels to 30, 50, 74 and 78 %, respectively, when
compared to the control group. Among all the doses
tested, 16 μg/mL of D. sephen venom showed increased
apoptotic levels in HeLa cells.
Changes in the levels of lipid peroxidative markers and
the activities of enzymatic antioxidants
We observed the levels of lipid peroxidative markers,
such as TBARS, CD and LHP in control and venom-
treated cells (Fig. 3). D. sephen venom treatment in-
creased the levels of lipid peroxidation in Hela cells.
Among all the concentrations (4, 8, 12, and 16 μg/mL)
tested, 16 μg/mL significantly increased levels of TBARS,
CD and LHP in HeLa cells.
Activities of enzymatic antioxidants such as SOD,
CAT, and GPxare are depicted in Fig. 4. D. sephen
venom (4, 8, 12, and 16 μg/mL) treatment signifi-
cantly decreased the activities of SOD, CAT, and GPx
in HeLa cells. Among all tested doses, 16 μg/mL of
D. sephen venom significantly decreased enzymatic ac-
tivities when compared with other doses in HeLa
cells. In this study, the effect of D. sephen venom on
glutathione levels in venom-treated cancer cells was
examined. Levels of GSH in control and venom-
treated cells are showed in Fig. 5. The treatment of
D. sephen venom (4, 8, 12, and 16 μg/mL) decreased
GSH levels in HeLa cells. Regarding all the doses
tested, 16 μg/mL of D. sephen venom significantly de-
creased GSH levels in HeLa cells.
Discussion
Venoms from many marine sources have demonstrated
to be highly effective in low concentrations. Marine fish
venoms have not been fully explored and their biological
potentials have not been completely characterized. In
the present study, we evaluated in vitro antiproliferative
potential of stingray venom extracts on HeLa cell line.
D. sephen venom venom significantly decreased the
viability of cancer cells. There was a significant increase
in cytotoxicity (26, 42, 68 and 80 %) of HeLa cells with
increasing concentrations of this venom at 4, 8, 12, and
16 μg/mL, respectively. Our results indicate that concen-
trations of the compounds play a vital role in cytotox-
icity. It is very likely that D. sephen venom may disrupt
mitochondrial dehydrogenase activity of cancer cells at
higher concentrations [29]. Mitogenic and cytotoxic ef-
fects of venom from marine sources such as S. verrucosa
and H. rubripinnis on regular and tumor cell lines have
been reported earlier [30]. However, the molecular role
of venom in disrupting intracellular signaling pathways
leading to apoptosis (programed cell death) of cancer
cells have not yet been elucidated [31]. Fleury et al. [32]
stated that an increase in the production of ROS associ-
ated with disturbance in the oxidative status results in
the impairment of mitochondrial function that triggers
the apoptosis pathway. Hence, in this study, assessment
of ROS species, mitochondrial function and antioxidant
enzyme activity determination was carried out.
ROS is known to be generated intracellularly though
three pathways: as the byproduct of normal aerobic
Fig. 1 Cytotoxicity of D. sephen venom on HeLa cells. The venom was incubated with cancer cells for 24 h and cytotoxicity was observed by MTT
assay. Cell death was observed in a concentration-dependent manner (2–20 μg/mL) in HeLa cells. Values were given as mean ± SD of six experiments
in each group. Values not sharing the same letter differ significantly (p < 0.05) from control (DMRT)
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metabolism; as second messengers in various signal
transduction pathways; and in response to environmen-
tal stress. Depending upon the concentration, ROS is
known to elicit a wide spectrum of biological responses
ranging from mitogenic to proliferative effects at low
concentrations, and macromolecular damage leading to
cell death at high concentrations [33]. Previous reports
have suggested that Okinawa habu apoxin protein-1
(OHAP-1) from Okinawa habu (T. flavovirudis) venom
induced apoptosis in malignant glioma cell lines by
promoting the generation of intracellular ROS [34].
Similarly, in our study D. sephen venom caused a rapid
increase of intracellular ROS levels (63 and 76 % at 12
and 16 μg/mL concentrations, respectively) in HeLa cells
after 24 h of incubation.
ROS are known to be generated from the reaction
of leaked electrons with oxygen under various systems
including lipid peroxidation. Lipid peroxidation is a
multistep process in which the initially formed lipid
radicals are converted to TBRS via the unstable inter-
mediate products CD and LPH [35]. We observed the
levels of lipid peroxidative products, such as TBARS, CD
and LHP in control and D. sephen venom-treated cells.
D. sephen venom treatment increased the levels of lipid
peroxidative products in HeLa cells. Among all the
concentrations tested (4, 8, 12, and 16 μg/mL), 16 μg/mL
of venom showed significantly increased levels of
TBARS, CD and LHP in HeLa cells.
Mitochondrion is one of the most important organ-
elles that regulate cell death and mark apoptosis [36].
Functional alterations of mitochondria have been shown
to play an important role in cell apoptosis [37]. The
mitochondria of normal cells pump H+ from initial
ground substance to the outside of the endomembrane
creating a transmembrane potential. In the present
study, mitochondria membrane potential was calculated
in order to examine whether apoptosis is accompanied
by the loss of mitochondrial transmembrane potential.
We observed D. sephen venom-treated cells showed sig-
nificantly decreased mitochondrial membrane potential
by 57, 35, 18, and 10 % at concentrations of 4, 8, 12, and
16 μg/mL, respectively, in HeLa cells when compared to
the control group. Rh-123, a mitochondria-specific mem-
brane permeable dye, was accumulated in the mitochon-
dria of control cells whereas venom-treated cells exhibited
decreased uptake of it with increasing concentrations. Our
results indicate that the mithochondrial damage occurred
during D. sephen venom treatment, which suggests that
the alteration of mitochondrial membrane potential
(MMP) may have a role in venom-induced cell death.
(See figure on previous page.)
Fig. 2 a Photomicrographs show the effect of D. sephen venom on: (i) intracellular ROS generation; (ii) mitochondrial membrane potential and;
(iii) apoptotic morphology changes in HeLa cells. b Effect of D. sephen venom on: (i) intracellular ROS generation; (ii) mitochondrial membrane
potential and; (iii) percentage of apoptosis in HeLa cells. Values were given as mean ± SD of six experiments in each group. Bars not sharing a
common letter differ significantly (p < 0.05) from control (DMRT)
Fig. 3 Effect of D. sephen venom on lipid peroxidation in HeLa cells. Bars represent the changes on the levels of lipid peroxidative markers
(TBARS, CD and LPH) in HeLa cells. Values were given as mean ± SD of six experiments in each group. Values not sharing the same letter differ
significantly (p < 0.05) from control (DMRT)
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HeLa cell death induced by venom might be due to mito-
chondrial toxicity, as the MMP collapsed before apoptosis.
This observation corroborates a previous study in which
treatment with the O. doriae venom induced reactive
nitrogen intermediates, caspase 3 and depolarization in
mitochondria [38].
Apoptosis plays an important role in determining cel-
lular cytotoxicity following drug treatment [39]. It is
known to be associated with a characteristic set of
morphological features, including membrane blabbing,
chromosomal condensation, nuclear fragmentation, cell
shrinkage and formation of apoptotic bodies. In the
present study, we observed that D. sephen venom pre-
treatment significantly increased morphological changes
associated in HeLa cells leading to 74 to 78 % of apoptosis
at concentrations of 12 to 16 μg/mL. Fluorescence micro-
scopic observation of the cells showed a typical apoptotic
morphology – cell pyknosis, chromosome condensation
and nuclear fragmentation in D. sephen venom-treated
cells when stained with EtBr/AO.
Acridine orange (AO) is a cationic dye known to pene-
trate the intact membrane of living cells and stain DNA.
On the other hand, EtBr is not incorporated by live cells.
Hence, control cells can be observed as green under blue
emission. On the contrary, cells undergoing apoptosis
are not able to exclude EtBr and then exhibit more
intense red color [40]. Increased ROS levels and loss of
mitochondrial membrane potential might be the reason
for increased apoptotic morphological changes such as
cell pyknosis and chromosome condensation observed
in the venom-treated cells.
Fig. 4 Effect of D. sephen venom on cellular antioxidant status in HeLa cells. Bars represent the changes on the activities of SOD, CAT and GPx in
control and venom treated cells. *Enzyme concentration required for 50 % inhibition of nitroblue tetrazolium reduction in one minute. **μmol of
hydrogen peroxide consumed per minute. ***μg of glutathione consumed per minute
Fig. 5 Effect of D. sephen venom on reduced GSH levels in HeLa
cells. Treated cells were incubated for 24 h at 37 °C and then
reduced GSH levels were measured in cell lysate. Values were given
as mean ± SD of six experiments in each group. Values not sharing
the same letter differ significantly (p < 0.05) from control (DMRT)
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In our body, antioxidant enzymatic defense is a very
important tool to neutralize oxygen free radical-
mediated tissue injury [41]. Free radical scavenging en-
zymes such as CAT, SOD, and GPx are the first line of
cellular defense against oxidative injury, decomposing
O2 and H2O2 before their interaction to form the more
reactive hydroxyl radical. Antioxidant enzymes can
antagonize initiation and promotion phases of carcino-
genesis and their levels are reduced in many malignan-
cies [42]. Cell malignancy or transformation is often
accompanied by decrease in activity of antioxidant en-
zymes like CAT, SOD, and GPx, which increases the cell
sensitivity to prooxidant compounds [43]. D. sephen
venom at concentrations of 4, 8, 12, and 16 μg/mL
significantly decreased the activities of SOD, CAT, and
GPx in HeLa cells. Among all the doses tested, 16 μg/mL
expressively decreased enzymatic activities when com-
pared with other doses in HeLa cells. It has been shown
in the literature that anticancer agents deplete intracellu-
lar antioxidants and because of that, there is increased
accumulation of free radicals inside the cells which
modulate the opening of the mitochondrial permeability
transition pore resulting in apoptosis [21, 35]. The
present finding indicates that the D. sephen venom has
caused cell death by damaging mitochondria, increasing
intracellular ROS formation and depletion of cellular
antioxidant enzyme in a dose-dependent manner in
HeLa cells. This corroborates a previous study that
showed the cytotoxic potential of Conus vexillum venom,
which induced oxidative stress [44].
GSH plays a key role in protecting cells from electro-
philic compounds and free radicals generated during
cellular metabolism. Depletion of GSH can lead to tumor
cell death in vitro, especially in melanocytic cells that
generate high levels of oxyradicals [45, 46]. In this study,
the effect of D. sephen venom on reduced glutathione
levels in HeLa cancer cells was examined. The treatment
with venom (4, 8, 12, and 16 μg/mL) decreased GSH levels
in HeLa cells. Among all the doses tested, 16 μg/mL sig-
nificantly decreased GSH levels in HeLa cells. The resist-
ance in most cases is associated with higher GSH levels
within these cancer cells. Thus, approaches to cancer
treatment could potentially benefit from a selective GSH
depleting strategy [47]. Therefore, our results indicate that
the prominent decrease of GSH levels in cancer cells
treated with D. sephen venom, and further purification of
its active constituents could lead to a novel drug
candidate.
Conclusions
The present findings suggest that D. sephen venom
initiates cancer cell death by decreasing cell prolifera-
tion, antioxidant status and mitochondrial membrane
potential; and by increasing intracellular ROS, lipid
peroxidation and apoptosis in human cervical (HeLa)
cancer cells. The current results clearly demonstrate the
involvement of an oxidative mechanism for the antipro-
liferative effect of D. sephen venom on HeLa cells. Thus,
marine stingray venoms could be used as a source of
antiproliferative agents after further purification in the
future.
Additional file
Additional file 1: Scientific classification and image of D. sephen.
(DOCX 105 kb)
Competing interests
The authors declare that there are no competing interests.
Authors’ contributions
RK, SK, MA, NR, RV contributed in the design, execution of the study and
interpretation of the data, TB and TV contributed intellectually in the
preparation of this manuscript.
Author details
1Ocular Pharmacology and Pharmacy, Centre for Ophthalmic Sciences, All
India Institute of Medical Sciences (AIIMS), New Delhi, India. 2Center of
Advanced Study in Marine Biology, Annamalai University, Parangipettai, Tamil
Nadu, India. 3Department of Biochemistry and Biotechnology, Annamalai
University, Tamil Nadu, India.
Received: 24 December 2014 Accepted: 15 September 2015
References
1. de Vries DJ, Beart PM. Fishing for drugs from the sea: status and strategies.
Trends Pharmacol Sci. 1995;16(8):275–9.
2. Aneiros A, Garateix A. Bioactive peptides from marine sources:
pharmacological properties and isolation procedures. J Chromatogr B Anal
Technol Biomed Life Sci. 2004;803(1):41–53.
3. Bhakuni DS. Some aspects of bioactive marine natural products. J Indian
Chem Soc. 1998;75:191–205.
4. Weinstein IB. Disorders in cell circuitry during multistage carcinogenesis:
the role of homeostasis. Carcinogenesis. 2000;21(5):857–64.
5. Kim MS, Kang HJ, Moon A. Inhibition of invasion and induction of apoptosis
by curcumin in H-ras-transformed MCF10A human breast epithelial cells.
Arch Pharm Res. 2001;24(4):349–54.
6. Calmette A, Saenz A, Costil L. Effets du venin de cobra sur les greffes
cancereuses et sur le cancer spontane (adenocarcinoma) de la souris.
CR Acad Sci. 1933;197:205–9.
7. Orsolic N, Sver L, Vestovsek S, Terzic S. Inhibition of mammary carcinoma
cell proliferation in vitro and tumor growth in vivo by bee venom.
Toxicon. 2003;41(7):861–70.
8. Wang WX, Ji YH. Scorpion venom induces glioma cell apoptosis in vivo and
inhibits glioma tumor growth in vitro. J Neurooncol. 2005;75(1):1–7.
9. Gupta SD, Gomes A, Debnath A, Saha A, Gomes A. Apoptosis induction in
human leukemic cells by a novel protein Bengalin, isolated from Indian
black scorpion venom: through mitochondrial pathway and inhibition of
heat shock proteins. Chem Biol Interact. 2003;183(2):293–303.
10. Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, et al. The
odyssey of marine pharmaceuticals: a current pipeline perspective. Trends
Pharmacol Sci. 2010;31(6):255–65.
11. Blunt JW, Copp BR, Keyzers RA, Munro MH, Prinsep MR. Marine natural
products. Nat Prod Rep. 2013;30(2):237–323.
12. Junghanss T, Bodio M. Medically important venomous animals: biology,
prevention, first aid, and clinical management. Clin Infect Dis.
2006;43(10):1309–17.
13. Fenner PJ, Williamson JA, Skinner RA. Fatal and non-fatal stingray
envenomation. Med J Aust. 1989;151(11–12):621–5.
Rajeshkumar et al. Journal of Venomous Animals and Toxins including Tropical Diseases  (2015) 21:41 Page 8 of 9
14. Conceição K, Konno K, Melo RL, Marques EE, Hiruma-Lima CA, Lima C, et al.
Orpotrin: a novel vasoconstrictor peptide from the venom of the Brazilian
stingray Potamotrygon gr. orbignyi. Peptides. 2006;27(12):3039–46.
15. Conceição K, Santos JM, Bruni FM, Klitzke CF, Marques EE, Borges MH, et al.
Characterization of a new bioactive peptide from Potamotrygon gr.
Orbignyi freshwater stingray venom. Peptides. 2009;30(12):2191–9.
16. Lalwani K. Animal toxins: scorpaenidae and stingrays. Br J Anaesth.
1995;75(2):247.
17. Weiss BF, Wolfenden DH. Survivor of a stingray injury to the heart.
Med J Aust. 2001;175(1):33–4.
18. Kumar KR, Vennila R, Kanchana S, Arumugam M, Balasubramaniam T.
Fibrinogenolytic and anticoagulant activities in the tissue covering the
stingers of marine stingrays Dasyatis sephen and Aetobatis narinari.
J Thromb Thrombolysis. 2011;31:464–71.
19. Haddad Junior V, Neto GD, de Paula Neto JB, de Luna Marques FP, Barbaro
CK. Freshwater stingrays: study of epidemiologic, clinic and therapeutic
aspects based on 84 envenomings in humans and some enzymatic
activities of the venom. Toxicon. 2004;43(3):287–94.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival:
application to proliferation and cytotoxicity assay. J Immunol Method.
1983;65(1–2):55–63.
21. Karthikeyan S, Prasad NR, Ganamani A, Balamurugan E. Anticancer activity of
resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung
cancer cells. Biomed Prev Nutr. 2013;3(1):64–73.
22. Niehaus Jr WG, Samuelsson B. Formation of malonaldehyde from
phospholipid arachidonate during microsomal lipid peroxidation.
Eur J Biochem. 1968;6(1):126–30.
23. Klein RA. The detection of oxidation in liposome preparations. Biochem
Biophys Acta. 1970;210(3):486–9.
24. Jiang ZY, Hunt JV, Wolff SP. Ferrous ion oxidation in the presence of xylenol
orange for detection of lipid hydroperoxide in low density lipoprotein.
Anal Biochem. 1992;202(2):384–9.
25. Kakkar ZYP, Das B, Viswanathan PN. A modified spectrophotometric assay of
superoxide dismutase (SOD). Indian J Biochem Biophys. 1984;21(2):130–2.
26. Sinha KA. Colorimetric assay of catalase. Anal Biochem. 1972;47(2):389–94.
27. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG.
Selenium: biochemical role as a component of glutathione peroxidase.
Science. 1973;179(4073):588–90.
28. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–7.
29. Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur J Biochem.
1998;252(1):1–15.
30. Satoh F, Nakagawa H, Yamada H, Nagasaka K, Nagasaka T, Araki Y, et al.
Fishing for bioactive substances from scorpionfish and some sea urchins.
J Nat Toxins. 2002;11(4):297–304.
31. Balasubashini MS, Karthigayan S, Somasundaram ST, Balasubramanian T,
Viswanathan P, Menon VP. In vivo and in vitro characterization of the
biochemical and pathological changes induced by lionfish [Pterois volitans]
venom in mice. Toxicol Mech Methods. 2006;16(9):525–31.
32. Fleury C, Mignotte B, Vayssiére JL. Mitochondrial reactive oxygen species in
cell death signaling. Biochimie. 2002;84(2–3):131–41.
33. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling
for suicide and survival. J Cell Physiol. 2002;192(1):1–15.
34. Sun LK, Yoshii Y, Hyodo A, Tsurushima H, Saito A, Harakuni T, et al.
Apoptotic effect in the glioma cells induced by specific protein extracted
from Okinawa Habu (Trimeresurus flavoviridis) venom in relation to
oxidative stress. Toxicol in Vitro. 2003;17(2):169–77.
35. Prasad NR, Karthikeyan A, Karthikeyan S, Reddy BV. Inhibitory effect of
caffeic acid on cancer cell proliferation by oxidative mechanism in human
HT-1080 fibrosarcoma cell line. Mol Cell Biochem. 2011;349(1–2):11–9.
36. Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, Kappler J, et al.
Reactive oxygen species regulate activation-induced T cell apoptosis.
Immunity. 1999;10(6):735–44.
37. Chou DA, Kuo YH, Jan MS, Chang YY, Chen YC, Chiu HL, et al. Caffeate
derivatives induce apoptosis in COLO 205 human colorectal carcinoma
cells through Fas- and mitochondria-mediated pathways. Food Chem.
2012;131:1460–5.
38. Zargan J, Sajad S, Umar M, Naime M, Ali S, Khan HA. Scorpion
(Odontobuthus doriae) venom induces apoptosis and inhibits DNA
synthesis in human neuroblastoma cells. Mol Cell Biochem.
2011;348(1–2):173–81.
39. Zhang L, Li H, Wu WT. Purification and characterization of cytotoxins from
Agkistrodon acutus venom and their anticancer activity. J Chin Pharm Sci.
2004;13(2):97–102.
40. Belloc F, Dumain P, Boisseau MR, Jalloustre C, Reiffers J, Bernard P, et al.
A flow cytometric method using Hoecht 33342 and propidium Iodide for
simultaneous analysis and apoptosis determination in unfixed cells.
Cytometry. 1994;17:59–65.
41. Polidoro G, Di Ilio C, Arduini A, La Rovere G, Federici G. Superoxide
dismutase, reduced glutathione and TBA-reactive products in erythrocytes
of patients with multiple sclerosis. Int J Biochem. 1984;16(5):505–10.
42. Matés JM, Sánchez-Jiménez FM. Role of reactive oxygen species in
apoptosis: implications for cancer therapy. Int J Biochem Cell Biol.
2000;32(2):157–70.
43. Abdel-Rahman MA, Abdel-Nabi IM, El-Naggar MS, Abbas OA, Strong PN.
Conus vexillum venom induces oxidative stress in Ehrlich’s ascites
carcinoma cells: an insight into the mechanism of induction. J Venomous
Anim Toxins Incl Trop Dis. 2013;19(1):10.
44. Sergediene E, Jonsson K, Szymusiak H, Tyrakowska B, Rietjens IM, Cenas N.
Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description
of quantitative structure activity relationships. FEBS Lett. 1999;462(3):392–6.
45. Estrela JM, Ortega A, Obrador E. Glutathione in cancer biology and therapy.
Crit Rev Clin Lab Sci. 2006;43(2):143–481.
46. Ortega AL, Carretero J, Obrador E, Gambini J, Asensi M, Rodilla V, et al.
Tumor cytotoxicity by endothelial cells. Impairment of the mitochondrial
system for glutathione uptake in mouse B16 melanoma cells that survive
after in vitro interaction with the hepatic sinusoidal endothelium. J Biol
Chem. 2003;278(16):13888–97.
47. Vad NM, Yount G, Moore D, Weidanz J, Moridani MY. Biochemical
mechanism of acetaminophen (APAP) induced toxicity in melanoma cell
lines. J Pharm Sci. 2009;98(4):1409–25.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Rajeshkumar et al. Journal of Venomous Animals and Toxins including Tropical Diseases  (2015) 21:41 Page 9 of 9
